A Phase 2 Study of JADE101 in Participants With Immunoglobulin A Nephropathy

NCT07541287 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jade Biosciences, Inc.